Intra Cellular Therapies shares owned by Group One Trading
Quarter-by-quarter ownership of Intra Cellular Therapies shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $329k | 4.5k | 73.17 |
| 2024-06-30 | $343k | 5.0k | 68.49 |
| 2024-03-31 | $990k | 14k | 69.20 |
| 2023-09-30 | $620k | 12k | 52.09 |
| 2023-06-30 | $1.3M | 20k | 63.32 |
| 2023-03-31 | $2.4M | 44k | 54.15 |
| 2022-12-31 | $561k | 11k | 52.92 |
| 2022-09-30 | $1.3M | 28k | 46.54 |
| 2022-06-30 | $1.6M | 29k | 57.09 |
| 2022-03-31 | $4.1M | 67k | 61.19 |
| 2021-12-31 | $4.6M | 89k | 52.35 |
| 2021-09-30 | $2.4M | 65k | 37.27 |
| 2021-06-30 | $2.1M | 51k | 40.82 |
| 2021-03-31 | $1.1M | 33k | 33.94 |
| 2020-12-31 | $3.1M | 97k | 31.80 |
| 2020-09-30 | $3.2M | 123k | 25.66 |
| 2020-06-30 | $3.7M | 142k | 25.67 |
| 2020-03-31 | $832k | 54k | 15.38 |
| 2019-12-31 | $13M | 380k | 34.31 |
| 2019-09-30 | $447k | 60k | 7.47 |
| 2019-06-30 | $635k | 49k | 12.99 |
| 2019-03-31 | $1.6M | 128k | 12.18 |
| 2018-12-31 | $7.9M | 692k | 11.39 |
| 2018-09-30 | $2.5M | 114k | 21.70 |
| 2018-06-30 | $1.1M | 60k | 17.67 |
| 2018-03-31 | $2.2M | 105k | 21.05 |
| 2017-12-31 | $350k | 24k | 14.46 |
| 2017-09-30 | $251k | 16k | 15.79 |
| 2017-06-30 | $75k | 6.0k | 12.50 |
| 2017-03-31 | $154k | 9.5k | 16.21 |
| 2016-12-31 | $59k | 3.9k | 15.13 |
| 2016-09-30 | $1.1M | 72k | 15.24 |
| 2016-06-30 | $2.5M | 64k | 38.82 |
| 2016-03-31 | $1.0M | 37k | 27.80 |
| 2015-12-31 | $441k | 8.2k | 53.78 |
| 2015-09-30 | $2.0M | 51k | 40.04 |
| 2015-06-30 | $6.0k | 200 | 30.00 |
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies